ArticleFrontiers in medicine2022

Memory T Cell Subpopulations as Early Predictors of Remission to Vedolizumab in Ulcerative Colitis.

Maria Gonzalez-Vivo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.